In this issue:
Dynamic contrast-enhanced MRI: correlates with MM stage and angiopoietin ratio
Daratumumab, pomalidomide + dexamethasone in relapsed/ refractory MM
Carfilzomib, cyclophosphamide + dexamethasone in newly diagnosed MM
Depth of response in MM
ctDNA, spatial mutational heterogeneity, and MM relapse
Daratumumab-based therapies in nontrial relapsed/refractory MM
Cardiac safety of bortezomib in MM
Autologous transplant outcomes in refractory MM
Impact of prior therapy on ixazomib regimen in relapsed/ refractory MM
Cytogenetic evolution in relapsed MM after autologous transplant
Please login below to download this issue (PDF)